421 Views | 358 Downloads
CONTACT Allison Ross Eckard, MD eckarda@musc.edu, Associate Professor of Pediatrics and Medicine, Divisions of Infectious Diseases, Medical University of South Carolina, 135 Rutledge Ave, Suite 1217, Charleston, SC 29425, USA
The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
GAM serves as a consultant for Bristol-Myers Squibb, ViiV/GlaxoSmithKline, Gilead, Pfizer, and ICON, and has received grant funding from Bristol-Myers Squibb, ViiV/GlaxoSmithKline, Merck, AstraZeneca, and Gilead.
All other declare no conflicts of interest.
This work was made possible by the National Institute of Child Health and Development at the National Institutes of Health [K23 HD069199 to ARE; R01 HD070490 to GAM; K12 HD072245 to AC; K23 HL123341 to CTL], Case Western Reserve University's Center for AIDS Research (P30 AI36219), Emory University's Center for AIDS Research (P30 AI050409), Emory+Children's Pediatric Research Center (Immunology and Flow Cytometry Cores), Clinical and Translational Science Award and the Clinical and Translational Science Collaborative of Cleveland (UL1TR000439) from the National Center for Advancing Translational Sciences (NCATS) component of the National Institutes of Health and NIH roadmap for Medical Research.
ARE has received research funding from Bristol-Myers Squibb, Cubist Pharmaceuticals, and GlaxoSmithKline and has served as an advisor and speaker for Gilead.
ARE has received research funding from Bristol-Myers Squibb, Cubist Pharmaceuticals, and GlaxoSmithKline and has served as an advisor and speaker for Gilead.
© 2018 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group